Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies

Journal article

Open access

Peer reviewed

Anastasia Gkiala and Sotiria Palioura

Clinical ophthalmology (Auckland, N.Z.), Vol.14, pp.3137-3152

2020

Abstract

c-KIT mutations

nivolumab

BRAF inhibitors

MEK inhibitors

CTLA4 inhibitors

vemurafenib

Review

immune checkpoint inhibitors

BRAF mutations

PD1 inhibitors

trametinib

pembrolizumab

NRAS mutations

ipilimumab

dabrafenib

url

https://doi.org/10.2147/OPTH.S271569View

Published (Version of record) Open

8 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies
Creators: Anastasia Gkiala - ,
Sotiria Palioura - ,
Publication Details: Clinical ophthalmology (Auckland, N.Z.), Vol.14, pp.3137-3152
Publisher: Dove
Grant note: ;
Academic Unit: UMMG Department of Ophthalmology
Language: English
Resource Type: Journal article
Record Identifier: 991031599871002976